Abstract
BackgroundSporozoite immunization of animals and humans under a chemo-prophylactic cover of chloroquine (CPS-CQ) efficiently induces sterile protection against malaria. In humans, CPS-CQ is strikingly more efficient than immunization with radiation attenuated sporozoites (RAS), raising the hypothesis that this might be partially due to CQ. Chloroquine, an established anti-malarial drug, is also well known for its immune modulating properties including improvement of cross-presentation. The aim of this study was to investigate whether co-administration of CQ during sporozoite immunization improves cellular responses and protective efficacy in Plasmodium berghei models.MethodsA number of experiments in selected complimentary P. berghei murine models in Balb/cByJ and C57BL/6j mice was performed. First, the effect of CQ administration on the induction of protection and immune responses by RAS immunization was studied. Next, the effect of CQ on the induction of circumsporozoite (CS) protein-specific CD8+ T cells by immunization with P. berghei parasites expressing a mutant CS protein was investigated. Finally, a direct comparison of CPS-CQ to CPS with mefloquine (MQ), an anti-malarial with little known immune modulating effects, was performed.ResultsWhen CQ was co-administered during immunization with graded numbers of RAS, this did not lead to an increase in frequencies of total memory CD8+ T cells or CS protein-specific CD8+ T cells. Also parasite-specific cytokine production and protection remained unaltered. Replacement of CQ by MQ for CPS immunization resulted in significantly reduced percentages of IFNγ producing memory T cells in the liver (p = 0.01), but similar protection.ConclusionsThis study does not provide evidence for a direct beneficial effect of CQ on the induction of sporozoite-induced immune responses and protection in P. berghei malaria models. Alternatively, the higher efficiency of CPS compared to RAS might be explained by an indirect effect of CQ through limiting blood-stage exposure after immunization or to increased antigen exposure and, therefore, improved breadth of the immune response.Electronic supplementary materialThe online version of this article (doi:10.1186/s12936-015-0626-2) contains supplementary material, which is available to authorized users.
Highlights
Sporozoite immunization of animals and humans under a chemo-prophylactic cover of chloroquine (CPS-CQ) efficiently induces sterile protection against malaria
Effects of chloroquine on radiation attenuated sporozoites (RAS) immunization First, experiments were performed to investigate whether administration of a prophylactic regimen of CQ improved CD8+ memory T cell responses induced by RAS immunization in C57BL/6j mice
The higher efficiency of Chemoprophylaxis and Sporozoites (CPS) compared to RAS in humans might be explained by an indirect effect of CQ through limiting blood-stage exposure after immunization or to an improved breadth of the immune response as a result of increased antigen exposure
Summary
Sporozoite immunization of animals and humans under a chemo-prophylactic cover of chloroquine (CPS-CQ) efficiently induces sterile protection against malaria. Chloroquine, an established anti-malarial drug, is well known for its immune modulating properties including improvement of cross-presentation. The aim of this study was to investigate whether co-administration of CQ during sporozoite immunization improves cellular responses and protective efficacy in Plasmodium berghei models. This study was based on the hypothesis that CQ, which affects endosomal acidification and the degradation and transport of antigens to the cytosol [22,23], could favour cross-presentation of pre-erythrocytic Plasmodium antigens and thereby contribute to the efficient induction of immune responses and protection by CPS-CQ immunization. By performing experiments in these selected complimentary P. berghei murine models, the aim of this study was to explore the effect of CQ on protection and T cell responses after whole sporozoite immunization
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.